Company / Operating Income per Share
Anixa Biosciences Inc Operating Income per Share History
FY2014-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.44
FY2024
5-year range
-$0.76 / -$0.44
FY2020-FY2024
Trend
+1.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 10 years, ranging from $-0.76 in FY2019 to $-0.04 in FY2014.
Based on SEC 10-K filings.
-0.44 in FY2024.
Remained stable around $-0.44 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating income per share increased 1.1% year-over-year.
- Peak operating income per share was recorded in FY2014.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.44 | +1.1% |
| FY2023 | -$0.45 | -2.7% |
| FY2022 | -$0.44 | +25.3% |
| FY2020 | -$0.58 | +22.6% |
| FY2019 | -$0.76 | -106.5% |
| FY2018 | -$0.37 | +29.0% |
| FY2017 | -$0.52 | -375.8% |
| FY2016 | -$0.11 | +81.1% |
| FY2015 | -$0.57 | -1417.1% |
| FY2014 | -$0.04 | -32.5% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026